Silicon Labs Posts Strong Q2 2026 Growth Amid Texas Instruments Acquisition — Silicon Laboratories, Inc. (Silicon Labs)

Event summary

Silicon Labs reported $228 million in revenue for Q2 2026, up 18% year-over-year.
Industrial & Commercial revenue grew 23%, while Home & Life revenue increased 12%.
Medical segment achieved record revenue, up 78% year-over-year.
Non-GAAP diluted earnings per share was $0.71, a 545% increase over the same period last year.
Company suspended forward-looking guidance due to pending acquisition by Texas Instruments.

The big picture

Silicon Labs' strong Q2 2026 results highlight its robust growth in key segments, particularly Industrial & Commercial and Medical. The pending acquisition by Texas Instruments introduces strategic uncertainty, as the company navigates integration challenges while maintaining its market position in low-power wireless connectivity solutions.

What we're watching

Integration Challenges: How the pending acquisition by Texas Instruments will impact Silicon Labs' operational independence and strategic direction.
Market Positioning: Whether Silicon Labs can sustain its growth trajectory in key segments like Industrial & Commercial and Medical amid regulatory uncertainties.
Financial Stability: The pace at which Silicon Labs can maintain profitability improvements post-acquisition, given the suspension of forward-looking guidance.